TPB Q2 2026 Net Sales Jump 22.6%
Modern Oral segment revenue surged 149% to $68.4 million amid tariff refunds, though net income dropped due to rising sales and marketing costs, while management raised FY 2026 guidance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day